ABBV vs CVS
By Alex · Tickerpine
AbbVie Inc. vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | CVS |
|---|---|---|
| Price | $295.03 | $89.35 |
| Market cap | $521.50B | $114.32B |
| P/E ratio | 50.7 | 10.4 |
| ROE | — | 14.36% |
| Profit margin | 15.67% | 2.64% |
| Revenue growth | 10.30% | 5.40% |
| Dividend yield | 2.35% | 2.98% |
| Beta | 0.19 | 0.58 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs CVS in plain English
- ABBV is the bigger company — about 4.6× the market cap of CVS.
- CVS is cheaper on earnings (P/E 10.4 vs 50.7).
- ABBV is growing revenue faster (10% vs 5%).
- CVS has the higher dividend yield (2.98% vs 2.35%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.